Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hewlett-Packard Company (HPQ), Xerox Corporation (XRX): Kodak’s Back, but Still Out of Focus

After 20 months under bankruptcy court protection, Eastman Kodak emerged yesterday a new company, free from the shackles of oversight, legacy costs, and debt. Yet having shed most of its assets, businesses, and patents that defined what had once been a venerable film and camera operation, today Kodak is neither fish nor fowl and there’s a lot of doubt about what the future holds.

Having rid itself of the worst of its costly expenses (and some of the best of its portfolio), Kodak is ready to restart as a narrowly focused commercial printer and imaging specialist, but on ground already paved by the likes of Hewlett-Packard Company (NYSE:HPQ) and Xerox Corporation (NYSE:XRX). It sold its personalized and document-imaging businesses to its U.K. pension plan for $650 million, just a fraction of the $2.8 billion in claims the retirement fund had sought, leaving Kodak with none of its consumer-oriented products and services. Instead, it will be a commercial enterprise-facing business.

Hewlett-Packard Company (NYSE:HPQ)

The stock that had been trading on the over-the-counter pink sheets is now no more. They have been retired and Kodak says that in the coming days it will be working on a new IPO, with its stock traded on one of the major exchanges, but under a new symbol.

Aside from the doubts about Kodak’s ability to navigate the smaller pond it chose to swim in, regardless of whether its a publicly traded company or not, even it recognizes that part of its operations are still in decline.

In an investor presentation to its creditors a few months ago, Kodak highlighted that revenue from its graphics, entertainment, and commercial films business was expected to decline from $1.7 billion in 2012 to $1.4 billion in 2017, a 3.3% compounded rate of contract. It’s hoping that its digital printing and enterprise business will more than make up for the shortfall by growing from less than a billion dollars last year to $1.7 billion, or a near 23% CAGR.

While Hewlett-Packard Company (NYSE:HPQ) and Xerox Corporation (NYSE:XRX) are bulwarks of the business, the space is highly competitive and they’re even facing difficulties as pricing and margins are pressed. Hewlett-Packard Company (NYSE:HPQ)’s earnings report last month indicated how difficult a road Kodak has in front of it. Despite selling 12% more commercial hardware units in its printing business, revenue in the segment declined 4% and its enterprise business didn’t look much better, with a 9% drop in revenue. Helpfully it remains profitable.

Xerox Corporation (NYSE:XRX) is also focusing more fully on business services, having reduced copiers and printing to little more than 40% of its revenue from nearly half two years ago. It was able to notch a 5% increase in revenue in the services space, but overall total revenue fell 3%, and analysts don’t foresee it recording much more than a 1% gain next year.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.